Peng Yuan
- Ophthalmology top 2%
- Retinal Diseases and Treatments 6
- Glaucoma and retinal disorders 5
- Cancer Research top 5%
- Breast Cancer Treatment Studies 14
- MicroRNA in disease regulation 5
- Oncology top 10%
- HER2/EGFR in Cancer Research 16
- Cancer Treatment and Pharmacology 8
- Pharmaceutical Science top 5%
-
- Advanced Breast Cancer Therapies 7
-
- Breast Lesions and Carcinomas 6
- Co-authors
- Michael R. RobinsonKarl G. CsakyRobert J. LutzHyuncheol KimGinger TanseyBinghe XuFei MaPeter M. Bungay
- Cited by
- OphthalmologyCancer ResearchOncology
- Journals
- Frontiers in Oncology (5 papers)Experimental Eye Research (3 papers)Cancer Medicine (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Peng Yuan
64 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 105
- Ophthalmology 298
- Cancer Research 347
- Oncology 409
- Radiology, Nuclear Medicine and Imaging 263
- Pharmaceutical Science 58
Countries citing papers authored by Peng Yuan
This map shows the geographic impact of Peng Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Yuan more than expected).
Fields of papers citing papers by Peng Yuan
This network shows the impact of papers produced by Peng Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Yuan. The network helps show where Peng Yuan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peng Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 13 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 6 | |
| 12 | 2020 | 14 | |
| 13 | 2016 | 86 | |
| 14 | 2016 | 27 | |
| 15 | 2016 | 5 | |
| 16 | 2015 | 21 | |
| 17 | 2013 | 1 | |
| 18 | 2006 | 51 | |
| 19 | Anterior Subtenon's Triamcinolone Acetonide (ASTTA) Injection for the Treatment of Diabetic Macular Edema: Animal and Clinical Findings | 2005 | 2 |
| 20 | 2002 | 37 |
About Peng Yuan
Peng Yuan is a scholar working on Cancer Research, Oncology and Ophthalmology, having authored 69 papers that have together received 1.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (16 papers), Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (8 papers), Advanced Breast Cancer Therapies (7 papers), Retinal Diseases and Treatments (6 papers), Breast Lesions and Carcinomas (6 papers), MicroRNA in disease regulation (5 papers) and Glaucoma and retinal disorders (5 papers). The work is most often cited by research in Ophthalmology (298 citations), Cancer Research (347 citations) and Oncology (409 citations). Peng Yuan has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Michael R. Robinson, Karl G. Csaky, Robert J. Lutz, Hyuncheol Kim, Ginger Tansey, Binghe Xu, Fei Ma, Peter M. Bungay, Martin J. Lizak and Pin Zhang. Their work appears in journals such as Frontiers in Oncology, Experimental Eye Research, Cancer Medicine, Scientific Reports and Therapeutic Advances in Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.